Hepatocellular Carcinoma (HCC) is a highly aggressive cancer with mortality running
parallel to its incidence and has limited therapeutic options. Chronic liver inflammation and …

Hepatocellular carcinoma (HCC) is one of the most common and deadly cancers worldwide.
It is usually diagnosed in an advanced stage and is characterized by a high intrinsic drug …

Liver cancer is the fourth leading cause of cancer-related death. Hepatocellular carcinoma
(HCC) is a primary liver cancer that results from chronic hepatitis caused by multiple …

Hepatocellular carcinoma (HCC) is the seventh most highly prevalent malignant tumor
globally and the second most common cause of mortality. HCC develops with complex …

Liver cirrhosis is associated with regenerative nodules and an increased risk of developing
hepatocellular carcinoma (HCC). However, other benign and malignant liver lesions may …

Alcoholic liver disease (ALD) is a global concern affecting most of the population and
leading to the development of end‐stage liver disease. Metabolic alterations due to …

Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …

Background Understanding how specific populations are affected by liver cancer is
important for identifying priorities, policies, and interventions to mitigate health risks and …

People living with HIV are living longer, high-quality lives; however, as they age, this
population is at increased risk for developing chronic comorbidities, including …

The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic
steatohepatitis (SUNN) study was a population-based screening study that aimed to provide …